WebJul 20, 2024 · "We believe this settlement represents the largest recovery in the over 150 years of False Claims Act cases to be secured by a whistleblower without the … WebConditioned upon the United States receiving the Settlement Amount from Biogen and as soon as feasible after receipt, the United States shall pay $3,960,000 to Relator by electronic funds transfer. 3. Subject to the exceptions in Paragraph 6 (concerning excluded claims) below, and
BIOGEN INC. AGREES TO PAY $900 MILLION TO RESOLVE …
WebSep 27, 2024 · The suit was filed in 2012 by Bawduniak, acting on behalf of the US government. Biogen will pay $844 million to the US government and another $56 million to 15 states within the next 20 days, with ... WebJul 21, 2024 · July 21, 2024. 2:56 pm. Source: Getty Images. Biogen’s Q2 earnings report was headlined by stronger than expected second-quarter sales for its multiple sclerosis drugs. Less touted the company’s disclosure that it had agreed in principle to pay about $900 million to settle an old whistleblower lawsuit involving some of the same products. derick postlethwaite
Pharmaceutical giant Biogen agrees to pay $900 million to settle ...
WebOct 6, 2024 · Under the terms of the settlement, the Company agreed to pay $843,805,187 to the United States and $56,194,813 to fifteen states. The Plaintiff will receive approximately 29.6% of the federal proceeds from the settlement or $250 million. The lawsuit was dismissed with prejudice. The settlement is significant for a number of reasons. WebJul 20, 2024 · The settlement ends a long-running battle that began in 2012, when a former Biogen sales manager named Michael Bawduniak filed a whistleblower lawsuit claiming the company ran thousands of speaker ... WebSep 21, 2024 · In one of the largest settlements ever secured by a whistleblower under the False Claims Act, the multinational pharmaceutical corporation Biogen agreed to pay $900 million in order to end a lawsuit related to an illegal kickback program. Attorney Thomas M. Greene, who represented the Biogen whistleblower, described the … chronic rhinosinusitis nasal polyposis